Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gadocoletic acid trisodium salt

Drug Profile

Gadocoletic acid trisodium salt

Alternative Names: B22956/1

Latest Information Update: 07 Sep 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bracco
  • Class Gadolinium-containing contrast agents; Organometallic compounds
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Coronary artery disease

Most Recent Events

  • 10 Apr 2007 Phase-II clinical trials in Coronary artery disease (diagnosis) in Italy (Injection)
  • 25 Feb 2005 A preclinical study has been added to the Ischaemic heart disease pharmacodynamics section
  • 05 Feb 2004 A clinical study has been added into adverse events, pharmacokinetics and Ischaemic heart disease pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top